Illumina next-generation sequencing (NGS) and microarray technologies are revolutionizing cancer research, enabling cancer variant discovery and detection and molecular monitoring.

Join us for a review of Illuminas areas of focus for development of sample-to-data solutions, including whole-genome and targeted sequencing approaches. Learn how these solutions are now delivering relevant oncological information into the hands of translational and clinical researchers. Hear about groundbreaking developments in cancer genomics from around the world, including:

• Whole-genome and targeted sequencing of DNA
• Germ line investigations
• Deep sequencing of circulating nucleic acids as non-invasive bio markers